儿童运动诱导的支气管收缩:从诊断到治疗的最新进展
Roberto Grandinetti1, Nicole Mussi1, Arianna Rossi1
1Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Journal of clinical medicine
|August 10, 2024
概括
运动引起的支气管收缩 (EIB) 导致运动后的呼吸道阻塞. 诊断包括运动测试和精神测量,治疗包括药物和行为策略.
科学领域:
- 肺部病理学 肺部病理学
- 运动医学 运动医学
- 儿科 儿科 儿科
背景情况:
- 运动诱导的支气管收缩 (EIB) 在喘中很常见,导致运动后的气道阻塞.
- 症状包括咳,呼吸不全,喘息,胸部紧张和疲劳.
- 讨论了机制,提出了透和热/血管理论.
研究的目的:
- 审查最近关于EIB病原,诊断和治疗的证据.
- 专注于年轻运动员的EIB管理.
- 提供有关诊断和治疗策略的最新信息.
主要方法:
- 评论过去10年出版的文学作品.
- 诊断方法的评估,包括螺旋测量和运动挑战测试 (例如,跑步机运行测试).
- 对不确定的诊断进行支气管诱导测试 (干燥空气呼吸高压,吸入曼尼托尔) 的评估.
主要成果:
- 标准化跑步机运行测试是用于诊断8岁以上儿童的EIB常见的.
- 药物治疗包括短效β-激动剂 (SABA) 和吸入性皮质类固醇 (ICS).
- 建议采用诸如热身,鼻呼吸和避免污染等行为策略.
结论:
- 精确诊断EIB需要排除其他条件,并使用运动挑战测试.
- 治疗包括运动前SABA,必要时每天ICS和行为修改的组合.
- 有效的EIB管理对于使年轻运动员参与体育运动至关重要.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192
Pulmonary Cycle: Exhalation
1.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
383
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
383
Antiasthma Drugs: β2-Adrenoceptor Agonists
243
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
243


